Copper: toxicological relevance and mechanisms
Tóm tắt
Từ khóa
Tài liệu tham khảo
Armstrong C, Leong W, Lees GJ (2001) Comparative effects of metal chelating agents on the neuronal cytotoxicity induced by copper (Cu2), iron (Fe3) and zinc in the hippocampus. Brain Res 892:51–62
Bleackley MR, Macgillivray RT (2011) Transition metal homeostasis: from yeast to human disease. Biometals 24:785–809
Braiterman LT, Murthy A, Jayakanthan S, Nyasae L, Tzeng E, Gromadzka G, Wolf TB, Lutsenko S, Hubbard AL (2014) Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B. Proc Natl Acad Sci U S A 111:E1364–E1373
Buettner G (1993) The packing order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol and ascorbate. Arch Biochem Biophys 300:535–543
Burkhead JL, Gray LW, Lutsenko S (2011) Systems biology approach to Wilson’s disease. Biometals 24:455–466
Burkitt MJ (2001) A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols and ceruloplasmin. Arch Biochem Biophys 394:117–135
Caliceti C, Nigro P, Rizzo P, Ferrari R (2014) ROS, Notch, and Wnt signaling pathways: crosstalk between three major regulators of cardiovascular biology. BioMed Res Int Article ID 318714, 8 pages, 10.1155/2014/318714
Chow CK (1979) Nutritional influence on cellular antioxidant defense systems. Am J Clin Nutr 32:1066–1081
Chow CK, Chow-Johnson HS (2013) Antioxidant function and health implication of vitamin E. Open Nutr J. 6:1–6
D’Autréaux B, Toledano MB (2007) ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8:813–824
de Romaña DL, Olivares M, Uauy R, Araya M (2011) Risks and benefits of copper in light of new insights of copper homeostasis. J Trace Elem Med Biol 25:3–13
Divertie MB, Owen CA Jr, Barham SS, Ludwig J (1982) Accumulation of radionuclide-labeled platelets and fibrinogen in paraquat-damaged rat lungs. Am Rev Respir Dis 125:574–578
Evans PJ, Halliwell B (1994) Measurement of iron and copper in biological settings: bleomycin and Cu-phenanthroline assays. Methods Enzymol 233:82–92
Fields M, Lewis CG, Bureau I (2001) Aspirin reduces blood cholesterol in copper-deficient rats: a potential antioxidant agent. Metabolism 50:558–561
Food and Nutrition Board and Institute of Medicine (2006) Dietary Reference Intakes. In: Otten JJ, Hellwig JP, Meyers LD (eds) The essential guide to nutrient requirements, copper. National Academy Press, Washington, pp 304–311
Fuentealba IC, Mullins JE, Aburto EM, Lau JC, Cherian GM (2000) Effect of age and sex on liver damage due to excess dietary copper in Fischer 344 rats. Clin Toxicol 38:709–717
Gaetke LM, Chow CK (2003) Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicol 189:147–163
Georgopoulos PG, Wang SW, Georgopoulos IG, Yonone-Lioy MJ, Lioy PJ (2006) Assessment of human exposure to copper: a case study using the NHEXAS database. J Expo Sci Environ Epidemiol 16:397–409
Goodman VL, Brewer GJ, Merajver SD (2004) Copper deficiency as an anti-cancer strategy. Endocr Relat Cancer 11:255–263
Gupta A, Lutsenko S (2009) Human copper transporters: mechanism, role in human diseases and therapeutic potential. Future Med Chem 1:1125–1142
Haidari M, Javadi E, Kadkhodaee M, Sanati A (2001) Enhanced susceptibility to oxidation and diminished vitamin E content of LDL from patients with stable coronary artery disease. Clin Chem 47:1234–1240
Halliwell B, Gutteridge JM (1984) Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219:1–14
Harris ED (1992) Copper as a cofactor and regulator of Cu, zinc superoxide dismutase. J Nutr 122:636S–640S
Harris E (1993) The transport of copper. In: Prasad AS (ed) Essential and toxic trace elements in human health and disease: an update. Wiley-Liss, New York, pp 163–179
Hasan NM, Lutsenko S (2012) Regulation of copper transporters in human cells. Curr Top Membr Transp 69:137–161
Hatori Y, Clasen S, Hasan NM, Barry AN, Lutsenko S (2012) Functional partnership of the copper export machinery and glutathione balance in human cells. J Biol Chem 287:26678–26687
Hayashi M, Kuge T, Endoh D, Nakayama K, Arikawa J, Takazawa A, Okui T (2000) Hepatic copper accumulation induces DNA strand breaks in the liver cells of Long/Evans Cinnamon strain rats. Biochem Biophys Res Commun 276:174–178
Huster D, Lutsenko S (2007) Wilson disease: not just a copper disorder. Analysis of a Wilson disease model demonstrates the link between copper and lipid metabolism. Mol BioSyst 3:816–824
Jomova K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicol 283:65–87
Kadiiska MB, Hanna PM, Jordan SJ, Mason RP (1993) Electron spin resonance evidence for free radical generation in copper-treated vitamin E- and selenium-deficient rats: invivo spin-trapping investigation. Mol Pharmacol 44:222–227
Kawanishi S, Inoe S, Yamamoto K (1989) Hydroxyl radical and singlet oxygen production and DNA damage induced by carcinogenic metal compounds and hydrogen peroxide. Biol Trace Elem Res 21:367–372
Kelner GS, Lee M, Clark ME, Maciejewski D, McGrath D, Rabizadeh S, Lyons T, Bredesen D, Jenner P, Maki RA (2000) The copper transport protein Atox1 promotes neuronal survival. J Biol Chem 275:580–584
Kim H, Wu X, Lee J (2013) SLC31 (CTR) family of copper transporters in health and disease. Mol Asp Med 34:561–570
Lang F, Ullrich S, Gulbins E (2011) Ceramide formation as a target in beta-cell survival and function. Expert Opin Ther Targets 15:1061–1071
Letelier ME, Faúndez M, Jara-Sandoval J, Molina-Berríos A, Cortés-Troncoso J, Aracena-Parks P, Marín-Catalán R (2009) Mechanisms underlying the inhibition of the cytochrome P450 system by copper ions. J Appl Toxicol 29:695–702
Letelier ME, Sánchez-Jofré S, Peredo-Silva L, Cortés-Troncoso J, Aracena-Parks P (2010) Mechanisms underlying iron and copper ions toxicity in biological systems: pro-oxidant activity and protein-binding effects. Chem Biol Interact 188:220–227
Levy MA, Tsai Y, Reaume A, Bray TM (2001) Cellular response of antioxidant metalloproteins in Cu/Zn SOD transgenic mice exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 281:L172–L182
Liang Q, Dedon PC (2001) Cu(II)/H2O2-induced DNA damage is enhanced by packaging of DNA as a nucleosome. Chem Res Toxicol 14:416–422
Linder MC, Hazegh-Azam M (1996) Copper biochemistry and molecular biology. Am J Clin Nutr 63:797S–811S
Linder MC, Wooten L, Cerveza P, Cotton S, Shulze R, Lomeli N (1998) Copper transport. Am J Clin Nutr 67:965S–971S
Long YC, Tan TMC, Inoue T, Tang BL (2014) The biochemistry and cell biology of aging: metabolic regulation through mitochondrial signaling. Am J Physiol Endocrinol Metab 306:E581–E591
Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY (2007a) Function and regulation of human copper-transporting ATPases. Physiol Rev 87:1011–1046
Lutsenko S, LeShane ES, Shinde U (2007b) Biochemical basis of regulation of human copper-transporting ATPases. Arch Biochem Biophys 463:134–148
Lynch SM, Frei B, Morrow JD, Roberts LJ, Xu A, Jackson T, Reyna R, Klevay LM, Vita JA, Keaney JF Jr (1997) Vascular superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arterioscler Thromb Vasc Biol 17:2975–2981
Marí M, Colell A, Morales A, Pañeda C, Varela-Nieto I, García-Ruiz C, Fernández-Checa JC (2004) Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor-induced lethal hepatitis. J Clin Invest 113:895–904
Medici V, Trevisan CP, D’Incà R, Barollo M, Zancan L, Fagiuoli S, Martines D, Irato P, Sturniolo GC (2006) Diagnosis and management of Wilson’s disease: results of a single center experience. J Clin Gastroenterol 40:936–941
Multhaup G (1997) Amyloid precursor protein, copper, and Alzheimer’s disease. Biomed Pharmacother 51:105–111
Multhaup G, Masters CL, Beyreuther K (1998) Oxidative stress in Alzheimer’s disease. Alzheimer Rep 1:147–154
Multhaup G, Hesse L, Borchardt T, Ruppert T, Cappai R, Masters CL, Beyreuther LK (1999) Autoxidation of amyloid precursor protein and formation of reactive oxygen species. Adv Exp Med Biol 36:365–387
Myers BM, Prendergast FG, Holman R, Kuntz SM, Larusso NF (1993) Alterations in hepatocytes lysosomes in experimental hepatic copper overload in rats. Gastroenterology 105:1814–1823
Ohhira M, Ono M, Sekiya C (1995) Changes in free radical metabolizing enzymes and lipid peroxides in the liver of Long-Evans with cinnamon-like coat rats. J Gastroenterol 30:619–623
Okereke T, Sternlieb I, Morell AG, Scheinberg IH (1972) Systemic absorption of intrauterine copper. Science 177:358–360
Olivares M, Méndez MA, Astudillo PA, Pizarro F (2008) Present situation of biomarkers for copper status. Am J Clin Nutr 88:859S–862S
Ossola JO, Groppa MD, Tomaro ML (1997) Relationship between oxidative stress and heme oxygenase induction by copper sulfate. Arch Biochem Biophys 337:332–337
Pandit A, Bhave S (1996) Present interpretation of the role of copper in Indian childhood cirrhosis. Am J Clin Nutr 63:830S–835S
Pankit AN, Bhave SA (2002) Copper metabolic defects and liver disease: environmental aspects. J Gastroenterol Hepatol 17:S403–S407
Pohl HR, Roney N, Abadin HG (2011) Metal ions affecting the neurological system. Met Ions Life Sci 8:247–262
Polishchuk R, Lutsenko S (2013) Golgi in copper homeostasis: a view from the membrane trafficking field. Histochem Cell Biol 140:285–295
Ralle M, Huster D, Vogt S, Schirrmeister W, Burkhead JL, Capps TR, Gray L, Lai B, Maryon E, Lutsenko S (2010) Wilson disease at a single cell level: intracellular copper trafficking activates compartment-specific responses in hepatocytes. J Biol Chem 285:30875–30883
Rivera-Mancía S, Pérez-Neri I, Ríos C, Tristán-López L, Rivera-Espinosa L, Montes S (2010) The transition metals copper and iron in neurodegenerative diseases. Chem Biol Interact 186:184–199
Rodriguez-Granillo A, Crespo A, Estrin DA, Wittung-Stafshede P (2010) Copper-transfer mechanism from the human chaperone Atox1 to a metal-binding domain of Wilson disease protein. J Phys Chem B 114:3698–3706
Rossi L, Arciello M, Capo C, Rotilio G (2006) Copper imbalance and oxidative stress in neurodegeneration. Ital J Biochem 55:212–221
Sansinanea AS, Cerone SI, Streitenberger SA, Garcia C, Auza N (1998) Oxidative effect of hepatic copper overload. Acta Physiol Pharmacol Ther Latinoam 48:25–31
Santos EM, Ball JS, Williams TD, Wu H, Ortega F, van Aerle R, Katsiadaki I, Falciani F, Viant MR, Chipman JK, Tyler CR (2010) Identifying health impacts of exposure to copper using transcriptomics and metabolomics in a fish model. Environ Sci Technol 44:820–826
Sayre LM, Perry G, Harris PLR, Liu YH, Schubert KA, Smith MA (2000) In situ oxidative catalysis by neurofibrillary tangles and senile in Alzheimer’s disease: a central role for bound transition metals. J Neurochem 74:270–279
Sokol RJ, Devereaux M, Mierau G, Hambidge KM, Shikes H (1990) Oxidant injury to hepatic mitochondrial lipids in rats with dietary copper overload. Gastroenterology 90:1061–1071
Song M, Zhou Z, Chen T, Zhang J, McClain CJ (2011) Copper deficiency exacerbates bile duct ligation-induced liver injury and fibrosis in rats. J Pharmacol Exp Ther 339:298–306
Squitti R, Bressi F, Pasqualetti P, Bonomini C, Ghidoni R, Binetti G, Cassetta E, Moffa F, Ventriglia M, Vernieri F, Rossini PM (2009) Longitudinal prognostic value of serum “free” copper in patients with Alzheimer’s disease. Neurology 72:50–55
Stern BR (2010) Essentiality and toxicity in copper health risk assessment: overview, update and regulatory considerations. J Toxicol Environ Health A 73:114–127
Strausak D, Mercer JF, Dieter HH, Stremmel W, Multhaup G (2001) Copper in disorders with neurological symptoms: Alzheimer’s, Menkes and Wilson diseases. Brain Res Bull 55:175–185
Su LC, Ravanshad S, Owen CA Jr, McCall JT, Zollman PE, Hardy RM (1982) A comparison of copper-loading disease in Bedlington terriers and Wilson’s disease in humans. Am J Physiol 243:G226–G230
Trumbo P, Yates AA, Schlicker S, Poos M (2001) Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc 101:294–301
Turnlund JR (1999) Copper. In: Shils ME, Olson JA, Shike M, Ross AC (eds) Modern nutrition in health and disease. Lippincott Williams and Wilkins, Baltimore
Turnlund J, Scott K, Peiffer G, Jang A, Keyes W, Keen C, Sakanashi T (1997) Copper status of young men consuming a low-copper diet. Am J Clin Nutr 65:72–78
Turnlund JR, Keyes WR, Peiffer GL, Scott KC (1998) Copper absorption, excretion, and retention by young men consuming low dietary copper determined by using the stable isotope 65Cu. Am J Clin Nutr 67:1219–1225
Uauy R, Maass A, Araya M (2008) Estimating risk from copper excess in human populations. Am J Clin Nutr 88:867S–871S
United States Environmental Protection Agency. 2013. Basic Information about Copper in Drinking Water. http://water.epa.gov/drink/contaminants/basicinformation/copper.cfm . Updated December 19, 2013
Vilaplana J, Romaguera C, Grimalt F, Cornellana F (1991) New trends in the use of metals in jewelry. Contact Dermatitis 25:145–148
Wang X, Moualla D, Wright JA, Brown DR (2010) Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity. J Neurochem 113:704–714
Wee NKY, Weinstein DC, Fraser ST, Assinder SJ (2013) The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease. Int J Biochem Cell Biol 45:960–963
White AR, Huang X, Jobling MF, Barrow CJ, Beyreuther K, Masters CL, Bush AI, Cappai R (2001) Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer’s-type neurodegenerative pathways. J Neurochem 76:1509–1520
Wijmenga C, Müller T, Murli IS, Brunt T, Feichtinger H, Schönitzer D, Houwen RH, Müller W, Sandkuijl LA, Pearson PL (1998) Endemic Tyrolean infantile cirrhosis is not an allelic variant of Wilson’s disease. Eur J Hum Genet 6:624–628
Wright LM, Huster D, Lutsenko S, Wrba F, Ferenci P, Fimmel CJ (2009) Hepatocyte GP73 expression in Wilson disease. J Hepatol 51:557–564
Yang CA, Chen YH, Ke SC, Chen YR, Huang HB, Lin TH, Chen YC (2011) Correlation of copper interaction, copper-driven aggregation, and copper-driven H2O2 formation with Aβ40 conformation. Int J Alzheimers Dis. doi: 10.4061/2011/607861
Zatta P, Drago D, Zambenedetti P, Bolognin S, Nogara E, Peruffo A, Cozzi B (2008) Accumulation of copper and other metal ions, and metallothionein I/II expression in the bovine brain as a function of aging. J Chem Neuroanat 36:1–5
Zhang SSZ, Noordin MM, Rahman SOA, Haron MJ (2000) Effects of copper overload on hepatic lipid peroxidation and antioxidant defense in rats. Vet Hum Toxicol 42:261–264